Articles
Clear, sourced financial journalism.
AllInformation TechnologyHealth CareFinancialsConsumer DiscretionaryCommunication ServicesIndustrialsConsumer StaplesEnergyUtilitiesReal EstateMaterials
Health Care
Aurora Therapeutics scraps lead program, cuts staff
Aurora Therapeutics, a startup building personalized gene-editing drugs, has scrapped its lead program and cut staff.
Aug 6, 2026
Health Care
Eli Lilly buys psychedelic drug developer AtaiBeckley
On July 16, 2026, Lilly agreed to buy AtaiBeckley for $2.8 billion upfront, with up to $1 billion more in milestone payments.
Jul 29, 2026